| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.076 | 0.06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |